Thus, the total effects of these HLA-DR+CD38hi CD8+ T cells and heterogeneous checkpoint molecules on immune response are difficultly computable in S/C cases of COVID-19, which reflected a broad and complicated dysregulation of T cell immunity. The gene discussed is CD8A; the disease is COVID-19.